Romanian private healthcare network MedLife has reached a market capitalisation of €1 billion at the Bucharest Stock Exchange (BVB), around nine years after the company went public.
MedLife, Romania's largest private healthcare network, announced financial results for the first nine months of 2025. The group recorded consolidated pro-forma revenue of over RON 2.36 billion (€464 million), up 19.5% compared to the same period in 2024. EBITDA pro-forma increased by 20.4% compared to the first nine months of last year.
Romanian private healthcare network MedLife is investing €3 million in genetic testing and will launch a large-scale genetic testing program.
Private healthcare services provider MedLife has opened its first fully automated laboratory in Brașov, following an investment exceeding €2 million.
Romanian private healthcare operator MedLife has announced the full acquisition of Cluj-Napoca-based clinics group Medstar.
Romanian private healthcare services provider MedLife has recorded a 20% y/y increase in pro-forma consolidated turnover during Q1 2025.
Romanian private healthcare group MedLife has announced an increase in its syndicated credit facility by €50 million, bringing the total to €330 million.
Romanian private healthcare player MedLife is extending its reach by acquiring a majority stake in All Clinic, a healthcare group in the Republic of Moldova.
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
According to the current shareholder structure, MedLife holds the majority stake - 60% - and Mihai Pavel, the group's founder, holds 40%.
In H2 2024, MedLife recorded consolidated pro forma revenue of RON 1.3 billion, up 24% compared to H1 2023, likely to exceed half a €500 million in revenue this year.
The new partnership will accelerate MedLife Group's development in the use of the latest genetic sequencing methodologies and technologies in routine diagnostics.
Electro-Alfa International, a Romanian electrical equipment manufacturer, has announced plans for an Initial Public Offering (IPO) on the Bucharest Stock Exchange (BVB).
Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.
Romania's Ministry of Finance will conduct its first public offering of Fidelis government bonds for 2026 between January 16 and 23 on the Bucharest Stock Exchange. This marks the 32nd offering since the Fidelis program resumed in July 2020.
Romania's final electricity consumption fell by 0.7% in the first 11 months of 2025 compared to the same period in 2024, according to data published by the National Institute of Statistics (INS).
Romania has the second-lowest consumer prices in the European Union, with costs 36% below the EU average in 2024, according to new Eurostat data released in December 2025.